New treatment from Vergent Bioscience able to visualize tumors in lung during surgery

Biotechnology company Vergent Bioscience has revealed that VGT-309, its investigational tumor-targeted fluorescent imaging agent, is able to help surgeons see lung tumors in real time during surgical procedures.

Related Keywords

John Santini ,Sunil Singhal ,Society Of Thoracic Surgeons ,Annual Meeting ,Thoracic Surgeons ,Perelman School ,Bio Developments ,Pipelines ,Emerging Markets ,Young ,Lung Cancer ,Ncology ,Humor ,